Effects of Trazodone on Sleep Quality and Cognitive Function in Arteriosclerotic Cerebral Small Vessel Disease Comorbid With Chronic Insomnia
Open Access
- 30 June 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 11, 620
Abstract
Background: Chronic insomnia is common in patients with arteriosclerotic cerebral small vessel disease (CSVD) and aggravates the cognitive impairment caused by CSVD. Low-dose trazodone is effective in treating insomnia, but it is unclear whether it can also improve cognitive function in CSVD patients. This study was performed to explore the effects of trazodone on sleep quality and cognitive function in CSVD comorbid with chronic insomnia. Methods: This was a randomized, double-blind, placebo-controlled pilot study. Forty patients suffering from arteriosclerotic CSVD and insomnia were recruited from an outpatient clinic. Participants were randomized individually to receive either trazodone (study group) or a placebo (control group) for 4 weeks. The primary outcome was the cognitive score on the Montreal Cognitive Assessment scale (MoCA). Secondary outcomes included sleep parameters measured with polysomnography (PSG) and the Pittsburgh Sleep Quality Index. Results: Trazodone caused significantly better improvements in concentration and recall abilities, measured with MoCA, as well as in PSG parameters such as sleep efficiency, N3 sleep ratio, and sleep continuity than the placebo, with no significant differences in the occurrence of side effects. The improvement of sleep quality was correlated with increased concentration and recall abilities. Conclusions: A low dose of trazodone seems acceptable and effective in reducing insomnia severity and improving concentration and recall abilities in this pilot study. The improvement of cognition could be achieved by alleviation of insomnia severity. Considering the high incidence of insomnia in CSVD patients, the results of this preliminary study support the use of low-dose trazodone to deal with insomnia and cognitive impairment in CSVD.Keywords
This publication has 48 references indexed in Scilit:
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationThe Lancet Neurology, 2013
- Rules for Scoring Respiratory Events in Sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated EventsJournal of Clinical Sleep Medicine, 2012
- The Beijing version of the montreal cognitive assessment as a brief screening tool for mild cognitive impairment: a community-based studyBMC Psychiatry, 2012
- Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacsJournal of Sleep Research, 2011
- Cognitive-behavioral therapy for insomnia improves attentional function in fibromyalgia syndrome: A pilot, randomized controlled trialJournal of Health Psychology, 2011
- Trazodone for the treatment of sleep disorders in dementia: an open-label, observational and review studyArquivos de Neuro-Psiquiatria, 2011
- The memory function of sleepNature Reviews Neuroscience, 2010
- Amartya Sen's Work and Ideas: A Gender PerspectiveAmerican Journal of Agricultural Economics, 2009
- Erratum: How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?Nature Clinical Practice Endocrinology & Metabolism, 2008
- Development of a fatigue scaleJournal of Psychosomatic Research, 1993